News from contractpharma.comFollowNews from contractpharma.comAll of today’s top news stories from contractpharma.com. Get the full analysis behind how media bias impacts breaking news.Ground News has come across 309 headlines reported on by contractpharma.com during the past 3 months. contractpharma.com’s aggregated media bias check is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is contractpharma.com credible or reliable? Our Factuality score answers both of those questions. When it comes to contractpharma.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.Follow All of today’s top news stories from contractpharma.com. Get the full analysis behind how media bias impacts breaking news. Ground News has come across 309 headlines reported on by contractpharma.com during the past 3 months. contractpharma.com’s aggregated media bias check is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is contractpharma.com credible or reliable? Our Factuality score answers both of those questions. When it comes to contractpharma.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check. Information about contractpharma.comWhere is contractpharma.com located?contractpharma.com's WebsiteMedia Bias RatingsDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: UnknownLearn more about Factuality Ratings.Top contractpharma.com NewsUnited States · United StatesFirst Brain-Delivered Gene Therapy Approved for AADC Deficiency100% Center coverage: 1 sources(MedPage Today) -- The FDA granted accelerated approval to eladocagene exuparvovec (Kebilidi) to treat children and adults with aromatic L-amino acid decarboxylase (AADC) deficiency, the agency announced Thursday. The treatment is the first approved...See the StoryQuotient Sciences Installs GMP Biofoundry-in-a-Box for RNA ProductionQuotient Sciences, a CDMO, reports that it has installed Centillion’s Biofoundry-in-a-Box (BiaB), a multi-product GMP platform technology for end-to-end RNA manufacture. BiaB is a modular, integrated, and automated RNA-micro factory that enables the processing of various RNA-based products, including messenger RNA (mRNA) and self-amplifying RNA (saRNA), and has the potential to significantly reduce the time it takes to bring RNA therapies to mar…See the StoryCambridge, Massachusetts · CambridgeHarbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer - PressReachCAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 14, 2024 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, is pleased to announce the appointment of Dr. Raymond Zheng as Chief Business Officer (CBO). Based in the United States, Dr. Zheng will lead global b…See the StoryLatest News StoriesTopics Most Covered by contractpharma.comCancerVaccinesMerckAstraZenecaArtificial IntelligenceCancerVaccinesMerckSources Covering Similar TopicsGEN - Genetic Engineering and Biotechnology News…pharmaceutical-technology.compipelinereviewcitybizstocktitan.netGEN - Genetic Engineering and Biotechnology News…pharmaceutical-technology.compipelinereviewSuggest a sourceLooking for a source we don't already have? Suggest one here.You've scrolled to the bottom of the feed, there are no more stories.
